End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
5-day change
1st Jan Change
1,770
KRW
+0.11%
+0.63%
-6.15%
Humasis Co. Ltd.'s Equity Buyback announced on February 26, 2024, has closed with 73,304 shares.
The company closed its plan on March 14, 2024.
Humasis Co. Ltd. announces an Equity Buyback for 17,533,607 shares.
Mar. 18
CI
Humasis Co. Ltd. authorizes a Buyback Plan.
Mar. 17
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on February 26, 2024.
Mar. 14
CI
Humasis Co. Ltd.'s Equity Buyback announced on February 26, 2024, has closed with 73,304 shares.
Mar. 13
CI
Humasis Co. Ltd. announces an Equity Buyback for 73,304 shares.
Feb. 26
CI
Humasis Co. Ltd. authorizes a Buyback Plan.
Feb. 24
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on May 18, 2023.
23-05-24
CI
Humasis Co. Ltd.'s Equity Buyback announced on May 18, 2023, has closed with 73,300 shares for KRW 185.45 million.
23-05-22
CI
Humasis Co. Ltd. announces an Equity Buyback for 73,300 shares.
23-05-18
CI
Humasis Co. Ltd. authorizes a Buyback Plan.
23-05-17
CI
Humasis Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-12
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on September 30, 2022.
23-03-29
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on September 30, 2022.
23-03-29
CI
Humasis Co. Ltd.'s Equity Buyback announced on September 30, 2022, has expired with 301,565 shares, representing 0.24% for KRW 5,140.7 million.
23-03-28
CI
7.6% stake in Humasis Co. Ltd. from Cha, Jung Hak, Oh, Min Jung, Oh, Jung Woo and Cha, Bo Yeon.
23-02-08
CI
ArtistCosmetics. Co., Ltd. agreed to acquire 7.6% stake in Humasis Co. Ltd. from Cha, Jung Hak, Oh, Min Jung, Oh, Jung Woo and Cha, Bo Yeon for KRW 65 billion.
23-01-26
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on September 30, 2022.
22-12-28
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on May 26, 2022.
22-11-25
CI
Humasis Co. Ltd.'s Equity Buyback announced on May 26, 2022, has expired with 1,456,252 shares, representing 2.74% for KRW 20,036.05 million.
22-11-24
CI
Humasis Co. Ltd. announces an Equity Buyback for KRW 20,000 million worth of its shares.
22-09-30
CI
Humasis Co. Ltd. authorizes a Buyback Plan.
22-09-29
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on March 16, 2022.
22-09-16
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on March 16, 2022.
22-09-16
CI
Humasis Co. Ltd.'s Equity Buyback announced on March 16, 2022, has expired with 706,367 shares, representing 2.07% for KRW 9,992.85 million.
22-09-15
CI
Tranche Update on Humasis Co. Ltd.'s Equity Buyback Plan announced on May 26, 2022.
22-08-25
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Humasis Co Ltd is a Korea-based company principally engaged in the manufacture and sale of in vitro diagnostic devices. The Company is engaged in the manufacture and sale of immunoquantitative analysis devices, myocardial infarction test equipment, infectious disease detection devices, hormone test devices, cancer marker test devices and other products. In addition, the Company is engaged in the research and development of biomaterials and other products. The Company sells its products within domestic market and to overseas markets. The Company was established in 2000 and is located in Gunpo-si, Gyeonggi-do, South Korea.
More about the company
1st Jan change
Capi.
-6.15% 164M +0.80% 12.8B -10.29% 7.61B -1.16% 4.51B +5.74% 4.49B -50.70% 3.3B +12.21% 2.73B -16.13% 2.02B -11.50% 1.73B -5.02% 1.64B
Diagnostic & Testing Substances
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1